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Introduction
normal except for persistent hypophosphataemia (serum inorganic phosphorus concentrations of 2.1-2.4 mg/dl ). Multiple determinations of serum calOncogenous osteomalacia is a rare paraneoplastic syncium and serum uric acid were within normal limits. drome characterized by bone pain, proximal muscle Serum concentrations of alkaline phosphatase (114 weakness and fractures, hypophosphataemia along IU/l ), parathyroid hormone (PTH ) (43 pg/ml ), 1,25-with hyperphosphaturia, and inappropriately low cirdihydroxycholecalciferol (25 pg/ml ), and 25-hydroxyculating concentrations of 1,25-dihydroxycholecalcifcholecalciferol (25 ng/ml ) were normal. Serum protein erol. This syndrome is associated with the presence of electrophoresis revealed a normal pattern. Twentytumours, and resolves after their excision [1] [2] [3] . The four-hour urinary inorganic phosphorus excretion tumours associated with this syndrome are usually ranged from 800 to 900 mg. The tubular phosphate benign, of mesenchymal origin, highly vascular, and reabsorption index of Brodehl [5] , i.e. [ TmP/GFR= composed principally of giant and spindle cells [4] . It P P −( U P ×P Cr /U Cr )] was less than 1.8 mg/dl. No evidis likely that this disorder is more common than ence of intestinal malabsorption, renal insufficency, suggested by the paucity of reports. Careful clinical metabolic acidosis, aminoaciduria, or glycosuria was examination for odd lumps is essential because the uncovered. diagnosis is frequently delayed [1] . We report a case Suspecting that we were dealing with tumourof oncogenous osteomalacia in a 51-year-old woman induced osteomalacia related to the subcutaneous mass with fibrocystic disease of the breast. She had a nodule in the left breast, the nodule was excised in July 1998. in the breast; after removal of the mass, all biochemical Histologic examination revealed an adenosclerotic abnormalities and clinical manifestations disappeared.
nodule and fibrocystic disease of breast, with numerous small thin-walled cysts and increasing hyalinised fibrous stroma ( Figure 1 ). Post-operatively, 12 weeks Case after surgery the patient was asymptomatic, her weakness had improved, and serum phosphate concen-A 51-year-old woman was referred from the tration (2.8 mg/dl ) as well as tubular phosphate Rheumatology Unit in May 1998 for evaluation of reabsorption (2.2 mg/dl ) had increased to normal persistent hypophosphataemia, i.e. 2.2 mg/dl (normal levels. Twenty-four-hour urinary inorganic phosphorus 2.5-4.9). Her illness began with diffuse bone pain in excretion was 600 mg/day. mid-1994. She experienced progressively increasing skeletal pain in the shoulders, knees, lower legs and back. The diffuse bone pain was accompanied by Discussion generalized muscular weakness leading to a severe debilitation, especially difficulty in walking. The elec-Tumour-induced (oncogenous) osteomalacia is a rare tromyogram and nerve conduction studies were metabolic bone disease in which phosphate homeonormal. The patient was not taking any medications. stasis is markedly deranged [1, 2] . To date, less than by McCance [9] in 1947, but the association between ledge, this is the first reported case of a nodule of fibrocystic disease of breast associated with oncotumour and osteomalacia was first recognized by Prader et al. [10] in 1959. It often presents with diffuse genous osteomalacia.
The reversal of clinical and biochemical abnormalitmuscle and bone pain, muscle weakness, and recurring fractures. It is characterized by two biochemical ies following removal of the tumour, indicates it is the source of a humoral factor (phosphatonin) that inhibits features that are the hallmark of this condition:hypophosphataemia and an inappropriately low 1,25-Na+-Pi cotransport in renal proximal tubular cells and reduces 1,25-dihydroxycholecalciferol production dihydroxycholecalciferol concentration [1, 2] . Serum calcium is normal or slightly low and alkaline phos- [2, 7] . This phosphaturic factor may be related to the circulating factor which is responsible for the renal Pi phatase is variably elevated. In our patient, as well as in other cases, the serum alkaline phosphatase concen-leak in X-linked hypophosphataemia, a genetic disease mimicked in many respects by oncogenous osteomalatration was normal [7] . Parathyroid hormone and 25-hydroxycholecalciferol levels are usually normal. The cia [2] . In light of the fact that PHEX, the gene responsible for X-linked hypophosphataemia, may be tubular phosphate reabsorption threshold (TmP/GFR) is low, i.e. less than 1.8 mg/dl [3] . In some patients, involved in the regulation of renal vitamin D metabolism and in the inactivation of a phosphaturic hormone other abnormalities of proximal renal tubular function have also been encountered, e.g. generalized amino-or the activation of a Pi-conserving hormone, it is of interest that PHEX transcripts have been detected in aciduria and renal glycosuria [12, 13] .
In oncogenic osteomalacia the syndrome is associ-tumours from patients with oncogenic osteomalacia [15] . The loss of PHEX function contributes to the ated with the presence of a tumour whose successful removal leads to clinical and biochemical cure. The pathophysiology of these disorders [15] . Tenenhouse recently studied Hyp and Gy mice that exhibit the tumours that cause this syndrome are often small and difficult to locate. They are generally of mesenchymal same phenotypic features that are found in patients with X-linked hypophosphataemia. The author identiorigin and are derived from soft tissue or bone. The most frequently reported tumour types are benign, fied a specific defect in Na+-Pi cotransport at the renal brush border membrane, abnormal regulation of 1,25-hemangioma, hemangiopericytoma, fibroma, fibroangioma and osteoblastoma [4, 6 ] , with variety of cell dihydroxyvitamin D3 synthesis and degradation, and an intrinsic defect in bone mineralization [15] . types, including spindle cells, osteoid and giant cells [4] . The tumours have been found in the popliteal region, the groin, the suprapatellar area, and the
